Prognostic value of microRNA expression in operable non-small cell lung cancer patients

BACKGROUND: About 50% of non-small cell lung cancer (NSCLC) patients develop distant metastases following pulmonary resection. Currently, there are no reliable factors allowing for individual selection of high-risk patients for adjuvant systemic therapies. METHODS: We assessed by quantitative revers...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzypski, M, Czapiewski, P, Goryca, K, Jassem, E, Wyrwicz, L, Pawłowski, R, Rzyman, W, Biernat, W, Jassem, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929871/
https://www.ncbi.nlm.nih.gov/pubmed/24448358
http://dx.doi.org/10.1038/bjc.2013.786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929871/
https://www.ncbi.nlm.nih.gov/pubmed/24448358
http://dx.doi.org/10.1038/bjc.2013.786

Ejemplares similares